Suchergebnisse - "Stagno, Fabio"

PubPharm (10)

1

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis

enthalten in: Blood | 2024

von Crespiatico, I. | Zaghi, M. | Mastini, C. | +37

CommentIn: Blood. 2024 Apr 4;143(14):1323-1324. - PMID 38573606

2

Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation

enthalten in: Blood | 2020

von Diral, E. | Mori, S. | Antolini, L. | +20

3

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response : the NEXT-in-CML study

enthalten in: Blood | 2020

von Soverini, S. | Bavaro, L. | De Benedittis, C. | +46

CommentIn: Nat Rev Clin Oncol. 2020 Apr;17(4):197. - PMID 31965084

4

Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia

enthalten in: Blood | 2013

von Russo, D. | Martinelli, G. | Malagola, M. | +23

ErratumIn: Blood. 2014 May 1;123(18):2902 Bergamaschi, Michela [corrected to Bergamaschi, Micaela]

5

Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia

enthalten in: Blood | 2013

von Russo, D. | Martinelli, G. | Malagola, M. | +22

6

Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia

enthalten in: Blood | 2009

von Rosti, G. | Palandri, F. | Castagnetti, F. | +21

7

Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study

enthalten in: Blood | 2009

von Rosti, G. | Palandri, F. | Castagnetti, F. | +20

8

Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase : a phase 2 trial of the GIMEMA CML Working Party

enthalten in: Blood | 2009

von Castagnetti, F. | Palandri, F. | Amabile, M. | +54

9

Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party

enthalten in: Blood | 2009

von Castagnetti, F. | Palandri, F. | Amabile, M. | +16

10

BCR-ABL nuclear entrapment kills human CML cells : ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B

enthalten in: Blood | 2006

von Aloisi, A. | Di Gregorio, S. | Stagno, F. | +10

1
[1]